Compound Radar

Envista Holdings Corporation (NVST) Stock Analysis

Price $26.81
Market cap $4.31B
Next earnings Oct 28, 2026
Entry status Wait $23.96–$25.44

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

64
64/100 Good Quality
  • Financial Health 75
  • Profitability 50
  • Business Quality 75
  • Balance Sheet 55
  • Cash Flow 60

Why this rating?

Health 64/100 — Good Quality

Strongest Financial Health 75/100
Softest Profitability 50/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Envista Holdings Corporation (NVST) is a Medical Instruments & Supplies company in the Healthcare sector. Compound Radar rates Envista Holdings Corporation 64/100 (Good Quality) due to high business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 46.22
  • Forward P/E 16.06
  • EV/Revenue 1.7

Profitability

  • Revenue Growth 7.1%
  • Gross Margin 55.4%
  • Operating Margin 10.4%
  • Net Margin 3.3%
  • ROE 3.1%

Financial strength

  • Cash $1.13B
  • Debt $1.59B
  • Net Cash $-462.40M
  • Free Cash Flow $230.40M
  • Current Ratio 2.43

Similar companies

Peers in Medical Instruments & Supplies, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Instruments & Supplies →

FAQ

How Compound Radar scores and tracks Envista Holdings Corporation (NVST).

View Methodology & FAQ →